SBIR/STTR Research Award

Genetic tool to enhance natural product gene expression

Award identifier 83413be943627344c06397ada9502afeb0c5c1129b171d6d75d80fd353238fb3Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$94,848

Program and phase

SBIR · Phase I

Award year

2005

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
EarthGenes Pharmaceuticals
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2005-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Although the vast majority of antibacterial are derived from microbes and new drugs are critically needed, many pharmaceutical companies have abandoned natural products because previous discovery paradigms seem no longer fruitful. However, because less than 2% of environmental microorganisms are cultivable by classical methods, the rest have not been screened. One method for accessing this potentially rich drug source is to shotgun clone large DNA fragments from uncultivated microbes, some of which may encode complete biosynthetic pathways, and screen them by a variety of biological and informatics-based methods, such as expressing the DNA in surrogate hosts and then screening for antibacterial activity. As different hosts provide different expression capabilities, using a variety of hosts is advantageous. We previously developed methods to create environmental DNA libraries by cloning large DNA fragments directly from soil samples into BAG vectors, then transferring them into 3 hosts: E. coli, S. lividans, and P. putida for expression and screening. We discovered a small environmental gene, rep, that significantly enhances type II PKS expression in streptomyces, thus increasing the chance of detecting low-level expression of environmental DNA. This proposal aims to further determine the scope of the ability of rep to enhance gene expression. Specifically, we will measure the expression of erythromycin (a type I PKS) and the calcium-dependent antibiotic (CDA, a NRPS) in the presence and absence of rep. To further enhance biodiversity and expression possibilities, we will also test the ability of rep to enhance expression of endogenous antibiotic clusters encoded by two marine microbes (S. arenicola and S. maritimus), and then assay the ability of rep to enhance expression of a marine cluster (enterocin) in S. lividans. Once the scope of expression enhancement effected by rep is determined, it can be inserted into selective expression hosts, possibly including a marine host, to optimize the detection of antibiotic biosynthetic genes in soil and marine environmental libraries.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.